Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
YoY growth seems to be great so far. It doesn't really matter too much where the money comes from, at the end of the day what matters is that they can demonstrate an ROI and hopefully that won't be blurred by more debt/credit/loan they take on. A fine line to be treaded as we approach profitability. You want to expand fast enough to enjoy the momentum, but you want to maintain a healthy cash flow to debt position.
Yes that cash balance was to the end Nov 21. So the fact that we haven’t raised yet indicates to me what the CFO said at the last investor meet me that we are funded from revenues holds true, well at least as each day goes by!
They also have a RCF they can use to flex any cash needs.
Usual caveats
Trek
"Gross cash balance at the period end of £2.97M (H1 2021: £3.28M) and net debt at the period end of £5.39M (H1 2021: £7.22M), after investment including capacity growth. The Company drew down an additional €3.0M (c.£2.50M) of debt post period end to fund the acceleration in the expansion of the US-based Commercial team, serviceable by cash generation from ImmunoINSIGHTS."
Just need to make sure we get to a point where net debt gets smaller and that funding can indeed come from revenues in immunoinsights (and also EarlyCDT)
I just want to confirm with anyone here that is knowlegeable. How long was the 8mio GBP funding supposed to last?
My concern is that if ONC run out of cash too fast and ask for more funding, it could seriously dent the SP again for a while.
It’s fine iPhone. I sold a load probably nearly a year ago now and have been buying back in recently. It’s not a fan show although I rate the company highly it’s about making money. I just think Matt Hall has expenses. The directors here are not on a gravy machine and their options are at 200p which imo we will see again here soon.
Finals in August are the next real catalyst.
See how the SP here is played on low vols. up 6% now lol!
I will be blue soon again at this rate!
Usual caveats
Trek
I was in ONC for a long time but sold at 1.85 to invest elsewhere as this was not moving fast. I wanted to come back in but the CFO selling has put me off.
Thanks Trek
I hope the shovels will be for gold here. I’m still holding but much longer and I’ll be shovelling something else!
Topped up yesterday and today. Should see this one recover soon. Bear market already lasted almost 200days, which by all accounts is a typical timeframe for sentiment to switch into a more positive direction. I think a little news on ONC would be welcome. Just a little update to keep us distracted from the other RNS. We need s9me good news to talk about ^^
Hi ingy,
When I last looked at IMM they were using CPI’s for Lupus. Their primary drug Lupizor was being funded for phase 3 trials. I haven’t looked at them for a while though as I didn’t like the corporate finance structure.
As for ONC and immunotherapy, we provide an immunodiagnostics service with our immunoINSIGHTS platform. I think had we had any involvement in that other than diagnostics our SP would be well north of £10 on rumours alone such is the size of the total addressable market (TAM).
That’s the beauty of ONC. We provide the diagnostics to the top Pharma’s. A bit like selling shovels in the gold rush!
Well you get the gist!
Good luck with your investments
Usual caveats
Trek
You often get small trades of the same volume and same time stamp or trades of various side with the same time stamp when MM’s are moving them across books/accounts.
I have seen from memory over 40 trades on GLO all the same number and all within seconds of each other. Then lots of other strange patterns. Like tens of single digit trades.
They are known as principle trades and it doesn’t matter what platform the instrument is listed on. SETS, SETSqx etc
It’s the MM role to generate liquidity but as the TR1’s here indicate the stock is being moved across UBS accounts.
The evidence points to that is what is happening. It’s the motive which is currently unknown.
Usual caveats
Trek
Just seen a report from USA announcing complete cure of 100% patients of rectal cancer using immunotherapy on its own. Not sure on all details but wondered how it may affect onc and imm
Of the six trades today, the first was mine and the other 5 all went through within 10 seconds of one another at 12:34.
Is that usual? A mix of ordinary and automatic trades. All showing as buys.
atb
Trek, good spot.
When do you think is the next news and what do you expect from results?
UBS AG London branch goes above 5% again!
You can see in box 4 which is only completed when the holding goes above 5%. It is then always UBS London branch.
So it looks like the London Branch is the buyer, taking the position above 5%. The shares then move to UBS group AG and they go below 5%.
Whenever the holdings go below 5% there is no additional info in the name in box 4, just that the parent companies holdings have now reduced.
They are using the Zurich office to gain an edge of the 5% notification for non uk holdings rather than 3% for uk.
I bet UBS are having a right laugh if they read this but imo it’s all smoke and mirrors with an ulterior motive to pick up ONC stock and move it on to another account(s) prior to a bid.
I am going nowhere and have actually added a few below 100p!
Usual caveats
Trek
So both the last two RNS’s say…
“ UBS trading book holdings in Oncimmune Holdings PLC fell below 5% and are therefore exempt from reporting”
Just the dates vary. So I can only assume that although 3 accounts are listed, group AG, AG and AG London, they must have had 5.481239% in one which crossed below 5% on the 2nd June and 5.449688% in another which crossed below 5% on 30th May.
The previous RNS took one account above threshold…etc
Really being played this. I don’t see UBS buying high and selling low for no reason.
With little liquidity and an often a sht spread it’s hardly a short term trading stock!
Usual caveats
Trek
I suppose the company is/ was busy wrapping up the year. No news for 1.5 months and last deal announcement 2 months ago...
Just grabbed a 100- shares. Pushed SP up 2p so if UBS are buying back again they can pay 100p! Lol!
Usual caveats
Trek
Again, all Greek to me!
Oncimmune @OncimmuneECDT · 58m
#ThursdayRead
Removing IL-6 from the mix prevents toxicity and boosts efficacy of checkpoint blockade https://bit.ly/39Uy12z
#ImmunoINSIGHTS #autoantibodies #Biomarkers #immunebiomarkers #clinicalresearch #immunooncology #checkpointinhibitors
Got a better price buying 10k than 5k. Not the case atm
Well at least that’s confirmation that it doesn’t seem to be anything ‘sinister’, in terms of a dump!
Yesterday’s large trades took UBS below threshold. They were likely all their sells (2x 150k and 1 x 157k) else if the later trade was a buy as it was at a higher SP it would not have resulted in a crossing.
So I can only assume UBS are moving stock on to another account/recipients/nominees etc.
All normal ‘abnormal’ behaviour if trying to build a position in a relatively illiquid stock. I saw similar trades at HZD and LID before a bid came in.
That’s NOT to say I am right in terms of a bid coming. Could be another reason.
I am just buying shares here so I am biased and as there are only a handful of posters here and no volume it will likely take ages to grab any meaningful numbers of shares here so I wouldn’t expect anything quick.
I also noticed how GLO share price was being held back with huge numbers of single trades followed by odd high UT trades end of day. I posted it there. Then look what followed!
DYOR and …..
Significant usual caveats!
Trek
457000 shares traded in 3 trades today, approx .66%. I am guessing sells, well at least 300k were.
300k is .43% ish., 157k is .227%ish just using the 69m here.
UBS at 5.398896%
Will be interesting to see if we get a UBS TR1 below 5% by Friday.
I was happy to nibble a few more lol!
I just can’t see that they are making money here. As itsyou has also alluded to I think they are buying and moving the stock on.
Usual caveats
Trek
Given we should be meaningfully profitable next year and we are likely on a low double digit P/E at these prices there is good buying indeed here right now. That said buying in size is hard unless you are prepared to spike the shareprice.
On the UBS TR1s we are seeing. It seems to me it relates to margin calls, given how they (UBS) are bouncing around it appears to be that someone large has this on margin. They are getting a margin call, UBS takes the collateral and starts to sell positions (probably across the portfolio with less impact here given the liquidity) the call is meet and the collateral is released. Given the volatility in the markets mirrors the UBS filings this is my best guess. I think this is borne out by the fact that each time UBS reports crossing 5% it is with less shares so the position has been trimmed down from the previous time they took the collateral.
A bit of forced selling and very few buyers is a good time to add a few as Trek is wisely doing.
Hi Trek,
Can't be Friday's trades as the date crossed was Thursday.
It's as if UBS are taking them, then moving them somewhere else. But there's no volume to support this.
I did email the company the other day, but no response, which is annoying. I could guess on what's going on, but that's all it would be.
9 TR1’s from UBS, oh! Okey okey Kokey!
I doubt it’s a fund thing rooster. Big Co and tiny ONC. They’d probably have a cash float for the little changes.
Could be working average or buying and moving stock to a nominee account. There were a couple of larger trades, marked as unknown Friday from memory. Was probably them,
I am not sure, only guessing. Don’t know if itsyou has any tech on it?
Ps I picked up a small amount again today.
Usual caveats
Trek
Last 6 RNS were all about UBS. ONC must be in some of their funds. I doubt this is UBS actively trading ONC stock but rather triggered investments/divestments from those funds by UBS customers?!